Tesamorelin
GHRH analog researched for visceral adiposity and lipid metabolism.
Testing & quality
Every batch is supplier-tested for identity and purity and randomly verified by independent third-party HPLC and mass spectrometry.
Compound classification
Stabilized 44-amino-acid GHRH analog (trans-3-hexenoyl-GHRH(1-44)).
Mechanism studied in the literature
Binds the GHRH receptor on pituitary somatotrophs and is studied in preclinical models for influence on the GH/IGF-1 axis and visceral adipose tissue biology.
Research areas
- GHRH receptor pharmacology
- Visceral adipose tissue research (preclinical)
- Lipid metabolism studies
- GH/IGF-1 axis modeling
Storage
Lyophilized: -20°C, protected from light. Reconstituted: 2-8°C, use within 28 days.
Reconstitution (laboratory)
Reconstitute with bacteriostatic or sterile water for injection (USP grade).
Related research peptides
CJC-1295 (No DAC)
Growth hormone releasing hormone analog studied for pulsatile GH release.
Ipamorelin
Selective GHRP studied for GH secretion without significant cortisol or prolactin impact.
GHRP-6
Growth hormone releasing peptide studied for GH secretion and appetite research.
Kisspeptin
Hypothalamic peptide studied for GnRH regulation and reproductive endocrinology.